|Bid||24.85 x 800|
|Ask||28.65 x 800|
|Day's Range||28.41 - 29.98|
|52 Week Range||16.13 - 32.34|
|Beta (5Y Monthly)||1.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 28, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 09, 2015|
|1y Target Est||34.58|
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021. The Company's virtual fireside chat is scheduled to begin at 11:00 a.m. ET.
CryoLife (CRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Joining me from CryoLife's management team are Pat Mackin, CEO; and Ashley Lee, CFO. Comments made on this call that look forward in time involve risks and uncertainties that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.